Vicarious Surgical Inc. (RBOT) Q2 2025 Earnings Call Transcript
Vicarious Surgical Inc. (NYSE:RBOT) Q2 2025 Earnings Conference Call August 12, 2025 4:30 AM ET
Company Participants
Adam David Sachs – Co-Founder, President & Director
Sarah Romano – CFO & Treasurer
Stephen From – CEO & Director
Conference Call Participants
Adam Carl Maeder – Piper Sandler & Co., Research Division
Eric Evan Anderson – TD Cowen, Research Division
Ryan Benjamin Zimmerman – BTIG, LLC, Research Division
Marissa Elizabeth Bych – Gilmartin Group LLC
Operator
Good afternoon. Thank you for attending the Vicarious Surgical’s 2025 Second Quarter Earnings Call. My name is Cameron, and I’ll be your moderator for today. [Operator Instructions] And I would now like to pass the conference over to your host, Marissa Bych from the Gilmartin Group. You may proceed.
Marissa Elizabeth Bych
Good afternoon. Today, after market close, Vicarious Surgical released financial results for the 3 months ended June 30, 2025. A copy of the press release is available on the company website. Before we begin, I’d like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
Any statements contained in this call that relate to expectations or predictions of future events, results or performance are forward- looking statements. All forward-looking statements, including, without limitation, those relating to obtaining approval for the Vicarious Surgical System and timing for any such approval, the timing of future clinical trials and FDA submissions, cash burn expectations, our operating trends and future financial performance, expense management, market opportunity and commercialization are based upon our current estimates and various assumptions.
These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated
